| Literature DB >> 35893925 |
Stephen Keenan1, Matthew B Cooke1, Won Sun Chen1, Sam Wu1, Regina Belski1,2.
Abstract
(1) Background: Excess weight in the form of adiposity plays a key role in the pathogenesis of cardiometabolic diseases. Lifestyle modifications that incorporate continuous energy restriction (CER) are effective at inducing weight loss and reductions in adiposity; however, prescribing daily CER results in poor long-term adherence. Over the past decade, intermittent fasting (IF) has emerged as a promising alternative to CER that may promote increased compliance and/or improvements in cardiometabolic health parameters independent of weight loss. (2)Entities:
Keywords: cardiometabolic; compliance; continuous energy restriction; intermittent fasting
Mesh:
Substances:
Year: 2022 PMID: 35893925 PMCID: PMC9370806 DOI: 10.3390/nu14153071
Source DB: PubMed Journal: Nutrients ISSN: 2072-6643 Impact factor: 6.706
Questions included within each survey category for hunger, cravings, mood and energy levels.
| Questions Included within Each Survey Category | |
|---|---|
| Hunger (maximum score possible 40) | 1. How hungry do you feel? (+ve) |
| Cravings (maximum score possible 40) | 1. Would you like something sweet? (+ve) |
| Energy levels (maximum possible score 40) | 1. How alert do you feel? (+ve) |
| Mood (maximum score possible 40) | 1. How sad do you feel? (−ve) |
| Compliance (maximum score possible 10) | 1. How compliant do you feel you were with your diet today? (+ve) |
+ve: values are positively associated with the domain; −ve: values are negatively associated with the domain and were transformed for subsequent analysis.
Participant baseline characteristics.
| Baseline Variable | IFT | CERT | |
|---|---|---|---|
| Age (years) | 24.7 (4.8) | 23.2 (3.9) | 0.31 |
| Height (m) | 1.72 (0.1) | 1.71 (0.1) | 0.82 |
| Weight (kg) | 80.1 (13.8) | 79.6 (13.5) | 0.92 |
| BMI (kg/m2) | 27.0 (2.7) | 27.1 (2.9) | 0.93 |
Note: Mean (SD). a p-values reported are for independent t-tests between intervention groups. BMI = body mass index.
Baseline values of cardiometabolic blood markers according to intervention group and sex.
| Baseline Variable | IFT Males | CERT Males ( | IFT Females | CERT Females | IFT Group ( | CERT Group ( | |
|---|---|---|---|---|---|---|---|
| hsCRP (mg/L) | 0.94 (0.64) | 1.41 (1.63) | 2.00 (1.82) | 2.43 (1.72) | 1.39 (1.34) | 1.92 (1.69) | 0.26 2 |
| TC (mmol/L) | 4.49 (0.79) | 4.18 (0.60) | 5.17 (1.02) | 4.18 (0.75) | 4.81 (0.94) | 4.18 (0.66) | 0.04 1 |
| Triglycerides (mmol/L) | 0.94 (0.26) | 1.20 (0.51) | 1.01 (0.36) | 0.90 (0.36) | 0.97 (0.30) | 1.05 (0.45) | 0.86 2 |
| HDL-C (mmol/L) | 1.35 (0.47) | 1.15 (0.32) | 1.83 (0.46) | 1.57 (0.43) | 1.57 (0.51) | 1.36 (0.42) | 0.22 |
| LDL-C (mmol/L) | 2.71 (0.63) | 2.49 (0.60) | 2.86 (0.78) | 2.19 (0.45) | 2.78 (0.68) | 2.34 (0.53) | 0.05 |
| Glucose (mmol/L) | 4.88 (0.33) | 4.90 (0.35) | 4.84 (0.42) | 4.76 (0.52) | 4.86 (0.36) | 4.83 (0.44) | 0.84 |
| Insulin (mU/L) 3 | 8.55 (4.54) | 10.26 (6.22) | 10.40 (2.73) | 11.89 (7.69) | 9.41 (3.80) | 11.08 (6.81) | 0.59 |
| HOMA-IR 3 | 1.88 (1.07) | 2.29 (1.60) | 2.27 (0.75) | 2.61 (2.02) | 2.06 (0.92) | 2.45 (1.77) | 0.64 |
Note: Mean (SD). 1 Significantly different between IFT and CERT. 2 Data from Mann–Whitney U test. 3 Presented values are non-transformed, and all analyses were conducted on Log10-transformed values to achieve normality. HDL-C = high-density lipoprotein cholesterol, hsCRP = high-sensitivity C-reactive protein, HOMA-IR = homeostatic model assessment of insulin resistance, LDL-C = low-density lipoprotein cholesterol, TC = total serum cholesterol.
The effects of 12 weeks of IFT or CERT with resistance exercise on cardiometabolic blood markers.
| Diet variable | Group | Baseline | Post Intervention | Δ | Δ (%) | ||||
|---|---|---|---|---|---|---|---|---|---|
| TC (mmol/L) 5 | IFT group ( | 4.81 (0.94) | 4.18 (0.71) | −0.63 | −13.1 | 0.20 | <0.001 1 | 0.01 2 | 0.92 |
| CERT group ( | 4.18 (0.66) | 3.98 (0.67) | −0.20 | 4.8 | |||||
| IFT males ( | 4.49 (0.79) | 4.03 (0.68) | −0.46 | −10.2 | |||||
| CERT males ( | 4.18 (0.60) | 3.79 (0.44) | −0.39 | −9.3 | |||||
| IFT females ( | 5.17 (1.02) | 4.36 (0.76) | −0.81 | −15.7 | |||||
| CERT females ( | 4.18 (0.75) | 4.18 (0.82) | 0.00 | 0.0 | |||||
| IFT group ( | 2.78 (0.68) | 2.26 (0.53) | −0.52 | −18.7 | 0.19 | <0.001 1 | 0.01 2 | 0.20 | |
| LDL-C (mmol/L) 5 | CERT group ( | 2.34 (0.53) | 2.17 (0.46) | −0.17 | −7.3 | ||||
| IFT males ( | 2.71 (0.63) | 2.23 (0.51) | −0.48 | −17.7 | |||||
| CERT males ( | 2.49 (0.60) | 2.10 (0.48) | −0.39 | −15.7 | |||||
| IFT females ( | 2.86 (0.78) | 2.30 (0.58) | −0.56 | −19.6 | |||||
| CERT females ( | 2.19 (0.45) | 2.24 (0.47) | 0.05 | 2.3 | |||||
| IFT group ( | 1.57 (0.51) | 1.47 (0.41) | −0.10 | −6.4 | 0.23 | 0.049 1 | 0.08 | 0.001 3 | |
| HDL-C (mmol/L) | CERT group ( | 1.36 (0.42) | 1.35 (0.38) | −0.01 | −0.7 | ||||
| IFT males ( | 1.35 (0.47) | 1.38 (0.44) | 0.03 | 2.2 | |||||
| CERT males ( | 1.15 (0.32) | 1.21 (0.35) | 0.06 | 5.2 | |||||
| IFT females ( | 1.83 (0.46) | 1.58 (0.38) | −0.25 | −13.7 | |||||
| CERT females ( | 1.57 (0.43) | 1.50 (0.37) | −0.07 | −4.6 | |||||
| IFT group ( | 4.86 (0.36) | 4.94 (0.30) | 0.08 | 1.6 | 0.91 | 0.09 | 0.55 | 0.35 | |
| Glucose (mmol/L) | CERT group ( | 4.83 (0.44) | 4.99 (0.34) | 0.16 | 3.3 | ||||
| IFT males ( | 4.88 (0.33) | 4.95 (0.28) | 0.07 | 1.4 | |||||
| CERT males ( | 4.90 (0.35) | 4.94 (0.27) | 0.04 | 0.8 | |||||
| IFT females ( | 4.84 (0.42) | 4.93 (0.32) | 0.09 | 1.9 | |||||
| CERT females ( | 4.76 (0.52) | 5.05 (0.41) | 0.29 | 6.1 | |||||
| IFT group ( | 9.41 (3.80) | 8.89 (2.76) | −0.52 | −5.5 | 0.95 | 0.21 | 0.29 | 0.79 | |
| Insulin (mU/L) 4 | CERT group ( | 11.08 (6.81) | 8.71 (4.94) | −2.37 | −21.4 | ||||
| IFT males ( | 8.55 (4.54) | 7.38 (2.13) | −1.17 | −13.7 | |||||
| CERT males ( | 10.26 (6.22) | 8.56 (5.59) | −1.70 | −16.6 | |||||
| IFT females ( | 10.40 (2.73) | 10.61 (2.43) | 0.21 | 2.0 | |||||
| CERT females ( | 11.89 (7.69) | 8.85 (4.59) | −3.04 | −25.6 | |||||
| IFT group ( | 2.06 (0.92) | 1.95 (0.60) | −0.11 | −5.3 | 0.96 | 0.36 | 0.36 | 0.73 | |
| HOMA-IR 4 | CERT group ( | 2.45 (1.77) | 1.99 (1.30) | −0.46 | −18.8 | ||||
| IFT males ( | 1.88 (1.07) | 1.62 (0.49) | −0.26 | −13.8 | |||||
| CERT males ( | 2.29 (1.60) | 1.93 (1.38) | −0.36 | −15.7 | |||||
| IFT females ( | 2.27 (0.75) | 2.32 (0.51) | 0.05 | 2.2 | |||||
| CERT females ( | 2.61 (2.02) | 2.05 (1.31) | −0.56 | −21.5 | |||||
| Non-normal variables | Group | Baseline | Post Intervention | Δ | Δ (%) | Signed rank Wilcoxon test (paired samples) | |||
| Group/sex | Diet group | ||||||||
| hsCRP (mg/L) | IFT group ( | 1.39 (1.34) | 1.39 (1.66) | 0.00 | 0.0 | Z = −1.13, | Z = 0.00, | ||
| CERT group ( | 1.92 (1.69)) | 1.21 (1.07) | −0.71 | −37.0 | Z = −1.16, | Z = −1.73, | |||
| IFT males ( | 0.94 (0.64) | 0.59 (0.35) | −0.35 | −37.2 | Z = 0.94, | ||||
| CERT males ( | 1.41 (1.63) | 1.07 (1.26) | −0.34 | −24.1 | Z = −1.36, | ||||
| IFT Females ( | 2.00 (1.82) | 2.45 (2.14) | 0.45 | 25.6 | |||||
| CERT females ( | 2.43 (1.72) | 1.36 (0.91) | −1.07 | −44.0 | |||||
| Triglycerides (mmol/L) | IFT group ( | 0.97 (0.30) | 0.98 (0.38) | 0.01 | 1.0 | Z = −0.53, | Z = −0.36, | ||
| CERT group ( | 1.05 (0.45) | 1.02 (0.41) | −0.03 | −2.9 | Z = −1.02, | Z = −0.35, | |||
| IFT males ( | 0.94 (0.26) | 0.93 (0.35) | −0.01 | −1.1 | Z = −0.18, | ||||
| CERT males ( | 1.20 (0.51) | 1.06 (0.47) | −0.14 | −11.7 | Z = −0.84, | ||||
| IFT females ( | 1.01 (0.36) | 1.04 (0.44) | 0.03 | 3.0 | |||||
| CERT females ( | 0.90 (0.36) | 0.98 (0.37) | 0.08 | 8.9 | |||||
Note: Mean (SD). 1 Significantly different than baseline at week 12 in all groups combined. 2 Significant time x diet group interaction. 3 Significant time x sex interaction. 4 Presented values are non-transformed, and all analysis were conducted on Log10-transformed values to achieve normality. 5 Analysis for TC and LDL-C adjusted for baseline values and weight change. Group = main effect for diet group, I = time x group interaction, S = time x sex interaction, Time = main effect for time, HDL-C = high-density lipoprotein cholesterol, hsCRP = high-sensitivity C-reactive protein, HOMA-IR = homeostatic model assessment of insulin resistance, LDL-C = low-density lipoprotein cholesterol, TC = total serum cholesterol, IFT = Intermittent Fasting Diet Group, CERT = Continuous Energy Restriction Diet Group.
Figure 1Individual changes from baseline to post intervention in (a) TC (IFT group), (b) TC (CERT group), (c) LDL-C (IFT group), (d) LDL-C (CERT group), (e) HDL-C (IFT group) and (f) HDL-C (CERT group).
The effects of 12 weeks of IFT and CERT with resistance exercise on mean ratings of hunger, cravings, energy levels, mood and compliance.
| Survey Variable | Group | Week 1 | Week 6 | Week 12 | Δ | Δ (%) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hunger (max. 40) | IFT group ( | 14.7 (3.9) | 13.6 (4.4) | 13.7 (5.2) | −1.0 | −6.8 | 0.63 | 0.22 | 0.49 | 0.03 2 |
| CERT group ( | 15.0 (5.2) | 11.3 (5.1) | 13.3 (6.4) | −1.7 | −11.3 | |||||
| IFT males ( | 16.5 (3.3) | 15.2 (4.9) | 13.9 (5.4) | −2.6 | −15.8 | |||||
| CERT males ( | 15.2 (4.6) | 11.4 (3.3) | 14.1 (4.7) | −1.1 | −7.2 | |||||
| IFT females ( | 12.8 (3.8) | 11.8 (3.1) | 13.6 (5.4) | 2.1 | 6.3 | |||||
| CERT females ( | 14.9 (5.8) | 11.2 (6.5) | 12.6 (7.8) | −2.3 | −15.4 | |||||
| Cravings (max. 40) | IFT group ( | 26.5 (5.0) | 30.2 (6.1) | 28.7 (8.2) | 2.2 | 8.3 | ||||
| CERT group ( | 28.1 (6.1) | 31.4 (7.0) | 31.0 (4.6) | 2.9 | 10.3 | |||||
| IFT males ( | 25.2 (4.9) | 29.2 (7.3) | 27.9 (5.2) | −2.7 | −10.7 | 0.46 | 0.08 | 0.96 | 0.20 | |
| CERT males ( | 29.3 (6.1) | 30.9 (8.4) | 30.6 (5.0) | 1.3 | 4.4 | |||||
| IFT females ( | 28.0 (5.0) | 31.4 (4.7) | 29.5 (10.8) | 1.5 | 5.4 | |||||
| CERT females ( | 27.1 (6.4) | 31.9 (6.0) | 31.3 (4.6) | 4.2 | 15.52 | |||||
| Energy levels (max. 40) | IFT group ( | 20.4 (4.6) | 22.2 (4.5) | 20.4 (6.8) | 0.0 | 0.0 | ||||
| CERT group ( | 20.1 (4.9) | 18.8 (4.1) | 18.9 (7.7) | −1.2 | −6.0 | |||||
| IFT males ( | 21.1 (4.0) | 23.2 (3.7) | 20.3 (5.5) | −0.8 | −3.8 | 0.61 | 0.77 | 0.37 | 0.18 | |
| CERT males ( | 21.5 (5.2) | 20.2 (5.2) | 21.7 (9.0) | 0.2 | 0.9 | |||||
| IFT females ( | 19.7 (5.3) | 21.0 (5.3) | 20.6 (8.3) | 0.9 | 4.6 | |||||
| CERT females ( | 18.9 (4.7) | 17.6 (2.3) | 16.4 (5.8) | −2.5 | −13.2 | |||||
| Mood (max. 40) | IFT group ( | 29.6 (4.5) | 29.0 (3.8) | 30.7 (4.5) | 1.1 | 3.7 | 0.06 | 0.02 1 | 0.14 | 0.07 |
| CERT group ( | 25.6 (5.8) | 24.0 (7.6) | 27.8 (6.8) | 2.2 | 8.6 | |||||
| IFT males ( | 30.0 (5.7) | 29.8 (3.6) | 31.1 (4.8) | 1.1 | 3.7 | |||||
| CERT males ( | 27.6 (3.0) | 24.0 (7.4) | 30.7 (2.8) | 3.1 | 11.2 | |||||
| IFT females ( | 29.2 (3.0) | 28.2 (4.2) | 30.2 (4.5) | 1.0 | 3.4 | |||||
| CERT females ( | 23.8 (7.1) | 24.1 (8.1) | 25.3 (8.5) | 1.5 | 6.3 | |||||
| Compliance (max. 10) | IFT group ( | 8.1 (1.1) | 8.4 (1.2) | 8.7 (1.6) | 0.6 | 7.4 | ||||
| CERT group ( | 8.1 (1.0) | 7.6 (1.8) | 8.1 (1.3) | 0.0 | 0.0 | |||||
| IFT males ( | 8.3 (0.8) | 8.8 (1.4) | 9.4 (0.8) | 1.1 | 13.3 | 0.25 | 0.31 | 0.90 | 0.08 | |
| CERT males ( | 8.5 (0.8) | 7.8 (1.6) | 8.3 (1.6) | −0.2 | −2.4 | |||||
| IFT females ( | 8.0 (1.2) | 8.1 (0.8) | 8.0 (2.0) | 0.0 | 0.0 | |||||
| CERT females ( | 7.7 (1.0) | 7.5 (2.0) | 7.8 (1.1) | 0.1 | 1.3 |
Note: Mean (SD). Δ represents change from week 1 to week 12. 1 Significantly different from weeks 4 and 9 in week 12 in all groups combined. 2 Significant main effect for sex. I = time x group interaction, S = main effect for sex, Time = main effect for time.
Figure 2Weekly mean ratings for hunger (a), cravings (b), energy levels (c), mood (d) and compliance (e) over 12 weeks for CERT and IFT participants. IFT = Intermittent Fasting Diet Group, CERT = Continuous Energy Restriction Diet Group. * No overlap in 95% confidence intervals.
Mean ratings for hunger, cravings, energy levels, mood and compliance separated by fasting and fed days in IFT participants over 12 weeks.
| Survey Variable | Group | Week 1 | Week 6 | Week 12 | Δ | Δ (%) | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| Hunger (max. 40) | IFT Males ( | 11.2 (3.2) | 9.7 (3.6) | 9.2 (3.5) | −2.0 | −17.9 | <0.001 1 | 0.32 | 0.34 | 0.01 2 |
| IFT Males ( | 26.5 (5.2) | 27.0 (6.3) | 26.7 (7.6) | 0.2 | 0.8 | |||||
| IFT Females ( | 7.7 (3.1) | 6.9 (4.0) | 7.6 (2.7) | −0.1 | −1.3 | |||||
| IFT Females ( | 23.6 (6.0) | 21.8 (6.4) | 22.4 (5.3) | −0.8 | −3.4 | |||||
| Cravings (max 40.) | IFT Males ( | 11.9 (4.6) | 7.0 (4.9) | 8.2 (4.8) | −3.7 | −31.1 | <0.001 1 | 0.21 | 0.94 | 0.04 2 |
| IFT Males ( | 19.1 (5.4) | 18.6 (5.3) | 21.8 (6.7) | 2.7 | 14.1 | |||||
| IFT Females ( | 7.8 (4.7) | 4.6 (3.1) | 4.5 (3.6) | −3.3 | −42.3 | |||||
| IFT Females ( | 19.9 (7.1) | 17.4 (8.7) | 17.6 (10.6) | −2.3 | −11.6 | |||||
| Energy levels (max. 40) | IFT Males ( | 21.8 (4.7) | 23.2 (4.6) | 21.8 (4.8) | 0.0 | 0.0 | 0.31 | 0.27 | 0.66 | 0.69 |
| IFT Males ( | 19.3 (5.4) | 22.2 (5.0) | 19.4 (7.4) | 0.1 | 0.5 | |||||
| IFT Females ( | 20.9 (6.7) | 21.6 (5.5) | 20.8 (7.2) | −0.1 | −0.5 | |||||
| IFT Females ( | 17.8 (3.7) | 19.6 (5.8) | 20.4 (7.9) | 2.6 | 14.6 | |||||
| Mood (max. 40) | IFT Males ( | 30.7 (4.7) | 30.4 (3.7) | 30.0 (3.8) | −0.7 | −2.3 | 0.06 | 0.09 | 0.59 | 0.06 |
| IFT Males ( | 28.5 (6.7) | 29.1 (4.2) | 28.0 (4.8) | −0.5 | −1.8 | |||||
| IFT Females ( | 30.0 (2.8) | 29.1 (3.2) | 28.4 (3.8) | −1.6 | −5.3 | |||||
| IFT Females ( | 26.4 (5.9) | 26.5 (4.4) | 27.4 (5.7) | 1.0 | 3.8 | |||||
| Compliance (max. 10) | IFT Males ( | 8.1 (0.7) | 8.6 (0.9) | 8.7 (0.9) | 0.6 | 7.4 | 0.06 | 0.26 | 0.68 | 0.02 2 |
| IFT Males ( | 9.1 (1.1) | 9.1 (1.2) | 9.5 (0.6) | 0.4 | 4.4 | |||||
| IFT Females ( | 7.9 (1.4) | 7.9 (0.6) | 8.0 (1.2) | 0.1 | 1.3 | |||||
| IFT Females ( | 8.6 (1.2) | 8.4 (1.9) | 8.3 (2.3) | −0.3 | −3.5 |
Note: Mean (SD). 1 Significant main effect for condition (fasted/fed). 2 Significant main effect for sex. C = main effect for condition (fasted/fed), CS = condition x sex interaction, S = main effect for sex, Time = main effect for time.
Bivariate correlations between survey measures according to intervention group.
| Survey Variable | Hunger | Cravings | Energy Levels | Mood | Compliance |
|---|---|---|---|---|---|
| CERT | |||||
| Hunger | 1.00 | −0.52 1 | 0.04 | −0.39 1 | −0.26 1 |
| Cravings | 1.00 | −0.07 | −0.15 2 | −0.33 1 | |
| Energy Levels | 1.00 | 0.51 1 | 0.11 | ||
| Mood | 1.00 | 0.34 1 | |||
| Compliance | 1.00 | ||||
| IFT | |||||
| Hunger | 1.00 | −0.71 1 | 0.10 | −0.12 | −0.05 |
| Cravings | 1.00 | 0.02 | 0.10 | −0.02 | |
| Energy Levels | 1.00 | 0.54 1 | 0.06 | ||
| Mood | 1.00 | 0.26 1 | |||
| Compliance | 1.00 |
Note: Spearman’s rho. 1 Significant correlation (p < 0.001). 2 Significant correlation (p < 0.05)
Post-intervention questionnaire responses to the dietary intervention in IFT and CERT participants.
| How Easy Was It to Comply with Your Diet? | Mean Score | |
|---|---|---|
| IFT | 6.6 (1.8) | 0.36 |
| CERT | 7.1 (1.3) | |
| Would you have preferred to have been in the other diet group? | Yes | No |
| IFT | 4 | 13 |
| CERT | 3 | 14 |
| Will you continue with your diet after the intervention period has finished? | Yes | No |
| IFT | 14 * | 3 |
| CERT | 15 * | 2 |
* Only one participant in the IFT group and two in the CERT group indicated that they would continue with their diet as prescribed; the remainder from each group noted that they would modify it in some way.